Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis
Clinical trial NCT01148953 · COMPLETED
Trial details
- NCT number
- NCT01148953
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-01-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.